Dopamine D4 Receptor Gene Variation Moderates the Efficacy of Bupropion for Smoking Cessation

Smokers (≥10 cig/day; N =331) of European ancestry taking part in a double-blind placebo-controlled randomized trial of 12 weeks of treatment with bupropion plus counseling for smoking cessation were genotyped for a VNTR polymorphism in Exon-III of the Dopamine D4 receptor (DRD4) gene. Generalized e...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Leventhal, Adam M., David, Sean P., Brightman, Molly, Strong, David, McGeary, John E., Brown, Richard A., Lloyd-Richardson, Elizabeth E., Munafò, Marcus, Uhl, George R., Niaura, Raymond
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2981689/
https://ncbi.nlm.nih.gov/pubmed/20661272
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/tpj.2010.64
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky